Drugs that contain Ketorolac Tromethamine

1. Drug name - ACULAR LS

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8008338 ALLERGAN Ketorolac tromethamine compositions for treating or preventing ocular pain
May, 2027

(4 years from now)

EP3217937A4 ALLERGAN Bed Systems And Methods
Nov, 2035

(13 years from now)

EP3217937B1 ALLERGAN Bed Systems
Nov, 2035

(13 years from now)

EP3217937A1 ALLERGAN Bed Systems
Nov, 2035

(13 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8648107 ALLERGAN Ketorolac tromethamine compositions for treating or preventing ocular pain May, 2024

(1 year, 8 months from now)

US8946281 ALLERGAN Ketorolac tromethamine compositions for treating or preventing ocular pain May, 2024

(1 year, 8 months from now)

US8377982 ALLERGAN Ketorolac tromethamine compositions for treating or preventing ocular pain May, 2024

(1 year, 8 months from now)

US8207215 ALLERGAN Ketorolac tromethamine compositions for treating or preventing ocular pain May, 2024

(1 year, 8 months from now)

US8541463 ALLERGAN Ketorolac tromethamine compositions for treating or preventing ocular pain May, 2024

(1 year, 8 months from now)

US9216167 ALLERGAN Ketorolac tromethamine compositions for treating or preventing ocular pain May, 2024

(1 year, 8 months from now)

US8906950 ALLERGAN Ketorolac tromethamine compositions for treating or preventing ocular pain May, 2024

(1 year, 8 months from now)

US8207215

(Pediatric)

ALLERGAN Ketorolac tromethamine compositions for treating or preventing ocular pain Nov, 2024

(2 years from now)

US8377982

(Pediatric)

ALLERGAN Ketorolac tromethamine compositions for treating or preventing ocular pain Nov, 2024

(2 years from now)

US8541463

(Pediatric)

ALLERGAN Ketorolac tromethamine compositions for treating or preventing ocular pain Nov, 2024

(2 years from now)

US8008338

(Pediatric)

ALLERGAN Ketorolac tromethamine compositions for treating or preventing ocular pain Nov, 2027

(5 years from now)

Treatment: A method of treating ocular pain; A method of treating or preventing ocular pain and burning/stinging following corneal surgery; A method of controlling postoperative ocular pain and burning/stinging in a patient; A method of treating or reducing ocular pain and burning/stinging; A method of treating ocular pain and/or enhancing ocular comfort; A method of treating or preventing ocular pain and burning

Dosage: SOLUTION/DROPS;OPHTHALMIC

More Information on Dosage
Strength Dosage Availability
0.4% SOLUTION/DROPS;OPHTHALMIC Prescription

2. Drug name - ACUVAIL

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7842714 ALLERGAN Ketorolac tromethamine compositions for treating ocular pain
Aug, 2029

(6 years from now)

CN102014869A ALLERGAN Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain
Sep, 2015

(7 years ago)

CN103976943B ALLERGAN Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain
Mar, 2029

(6 years from now)

CN103976943A ALLERGAN Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain
Mar, 2029

(6 years from now)

CN102497856B ALLERGAN For Treating Or Prevention Eye Pain Of Ketorolac Tromethamine Composition
Aug, 2030

(7 years from now)

CN102497856A ALLERGAN Ketorolac Tromethamine Composition For Treating Or Preventing Eye Pain
Aug, 2030

(7 years from now)

IN286644B ALLERGAN Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain
Mar, 2029

(6 years from now)

IN201006461P1 ALLERGAN Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain
Mar, 2029

(6 years from now)

EP2257275A2 ALLERGAN Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain
Mar, 2029

(6 years from now)

EP2257275B1 ALLERGAN Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain
Mar, 2029

(6 years from now)

EP2446878B1 ALLERGAN Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain
Mar, 2029

(6 years from now)

EP2446878A1 ALLERGAN Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain
Mar, 2029

(6 years from now)

EP2473157A1 ALLERGAN Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain
Aug, 2030

(7 years from now)

EP2473157B1 ALLERGAN Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain
Aug, 2030

(7 years from now)

EP2555770B1 ALLERGAN Ketorolac Compositions For Corneal Wound Healing
Apr, 2031

(8 years from now)

EP2555770A1 ALLERGAN Ketorolac Compositions For Corneal Wound Healing
Apr, 2031

(8 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8992952 ALLERGAN Compositions for delivery of therapeutics into the eyes and methods for making and using same Aug, 2024

(1 year, 10 months from now)

US8512717 ALLERGAN Compositions for delivery of therapeutics into the eyes and methods for making and using same Mar, 2028

(5 years from now)

US9192571 ALLERGAN Ketorolac tromethamine compositions for treating or preventing ocular pain Mar, 2028

(5 years from now)

Treatment: NA

Dosage: SOLUTION/DROPS;OPHTHALMIC

More Information on Dosage
Strength Dosage Availability
0.45% SOLUTION/DROPS;OPHTHALMIC Prescription

availability in other generic markets.

Click on the highlighted region to filter.